A multicenter, randomized, placebo-controlled trial to compare sacral neuromodulation versus placebo in patients with multiple sclerosis with neurogenic lower urinary tract, bowel and sexual dysfunction

Authors
Category Primary study
JournalEuropean urology
Year 2026
This article has no abstract
Epistemonikos ID: 4cc85ffc270279a75fcd68f883b5391948bea2f5
First added on: Jun 06, 2026